Eli Lilly's Stock Fall Is An Opportunity (NYSE:LLY)

Eli Lilly's robust R&D, strong pipeline, and leadership in diabetes, obesity, and oncology underpin its long-term growth prospects. Read why LLY stock is a Buy.